US EditionTrump signs executive order slashing prescription drug costs by up to 80%
- President Donald Trump signed an executive order on Monday at the White House to lower U.S. Prescription drug prices by linking them to lower costs abroad.
- The order revives the controversial "Most Favored Nation" policy, which ties U.S. Drug prices to the lowest prices paid by other countries, despite past legal challenges.
- The executive order requires drug manufacturers to enter price negotiations with the Health Department within a month and warns of potential federal investigations and increased drug imports if an agreement is not reached.
- Trump stated that prescription drug costs should decrease by a minimum of 59 percent, emphasizing that the prices Americans pay will be aligned with the lowest rates paid by other countries.
- The order could reduce costs for Medicare and Medicaid recipients but faces opposition from pharmaceutical industry lobbyists who call it a 'bad deal' for American patients.
545 Articles
545 Articles
Decree: Trump blames "socialist health system in Germany" for high drug prices in the USA
The Americans would be excluded by the pharmaceutical companies because Europeans are capping drug prices, according to the US President. A decree is now to change this. At the same time, he wants to make drastic savings in health insurance for poorer citizens.
'All hat and no cattle': Democrats call Trump's bluff on drug price Executive Order
If U.S. President Donald Trump actually wants to curb out-of-control prescription drug prices, he'll throw his support behind legislative efforts instead of trying to do so unilaterally—an approach that's unlikely to survive legal challenges. That was the message that Sen. Bernie Sanders (I-Vt.) and congressional Democrats sent to the White House after Trump signed an executive order Monday aimed at pushing "pharmaceutical manufacturers to bring…
Coverage Details
Bias Distribution
- 50% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
